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Introduction

Chest X-ray

Discussion

• Sarcoidosis is a multisystem inflammatory disease, characterized by
noncaseating granulomas, the pathologic hallmark of the disease.

• Peripheral neuropathy is a rare manifestation of sarcoidosis, with a
prevalence of approximately 5-15% among patients with known sarcoidosis.

• Extrapulmonary manifestations involving the skin, ophthalmologic,
gastrointestinal and cardiovascular systems can develop in 30-50% of
sarcoidosis patients.

• Isolated neurosarcoidosis occurs in less than 1% of patients, in which
patients often do not show any other signs of extra neural involvement.
• Peripheral neuropathy in sarcoidosis can have varied presentations,
including distal symmetric polyneuropathy, focal or multifocal neuropathy
and mononeuritis multiplex.

• Neurosarcoidosis is a rare variant.
• We report a unique case of a 42-year-old female with progressively
worsening bilateral lower extremity weakness, who was diagnosed with
peripheral neuropathy secondary to sarcoidosis.

• The pathophysiology is believed to be the activation of inflammatory cells,
which release toxic secretory products that cause local tissue inflammation.
• The diagnosis is confirmed if presence of neurosarcoidosis occurs together
with the histopathologic or clinical evidence. Histopathological evidence of
noncaseating granulomatous inflammation from neural tissue is the hallmark
of definite diagnosis.

Background
Case
• 42-year-old Caucasian female with a past medical history of diabetes mellitus
type 2 presented with a six month history of progressively worsening bilateral
lower extremity weakness.

• Spontaneous remission can occur within six months, however this is a very
rare occurrence. Immunosuppression is the hallmark of therapy and
corticosteroids are the mainstay of treatment.

• She also reported mild upper extremity weakness, numbness, tingling and a
unilateral left-sided facial weakness.
• Physical examination demonstrated a left-sided facial droop and ptosis of the left
eye. Muscle tone, power and sensations were decreased in the bilateral lower
extremities. Reflexes were absent in both upper and lower extremities

Conclusion
• The purpose of our case is to shed light on the rare manifestations of
neurosarcoidosis, and the need for further research to develop more
effective diagnostic and therapeutic strategies.

Investigations
• CT Brain was negative, however chest x-ray showed bilateral hilar adenopathy.
• Cerebrospinal fluid (CSF) studies revealed an elevated protein of 316 mg/dL
with an elevation in WBC of 70 WBC/uL with predominant lymphocytes with
negative VDRL and West Nile serology.

Figure: 1
Chest X-ray showing bilateral hilar lymphadenopathy

• Electromyography studies showed mixed axonal polyneuropathy with no patchy
demyelination.
• Bronchoscopic biopsy of the mediastinal tracheobronchial lymph nodes showed
non caseating granulomas, consistent with sarcoidosis.

Hospital Course
• Patient was started on oral Prednisone 60 mg daily.
• Within three days, she reported moderate improvement in her symptoms.
• She was continued on Prednisone 60 mg oral daily for one month, with a gradual
taper of 5 mg per month.
• She was followed up for 2 months and was doing well on maintenance dose
steroids of 10 mg/day and physical therapy.
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• Although challenging, a high index of suspicion is required to properly
diagnose and treat these rare presentations of this common disease, in
order to prevent morbidity associated with sarcoidosis.
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